News

Orange County-based lender Pelorus recently announced a $1B fund to place equity investments in cannabis companies. The firm sees opportunity to buy into distressed operators, of which there’s no shortage. And the number of targets seems certain to grow as the industry approaches its $6B “debt wall” next year. In an interview with WeedWeek, managing director Henry Miller said they aim to build “a carefully selected portfolio of strong operating assets.”

The U.S. Supreme Court has narrowed its list of pending cases concerning the federal ban on gun ownership by people who use marijuana, with justices declining to take up one of about a half dozen-with the others now set to be discussed by the justices at a closed-door meeting on Friday. On Tuesday, the court denied a petition for cert in U.S. v. Baxter, which involves a challenge to the federal statute known as Section 922(g)(3). That isn’t especially surprising, however, as both the Justice Department and Keshon Daveon Baxter, the man being prosecuted in the case, advised against further . . .

The company’s agreement represents the largest revolving credit facility in the U.S. cannabis sector.

North Carolina has the opportunity to “lead the nation” in expanding access to psychedelic medicine for military veterans suffering from major mental health conditions, a Republican state senator says. At an event organized by Students for Sensible Drug Policy (SSDP), Veterans Exploring Treatment Solutions (VETS) and the North Carolina Psychedelic Policy Coalition, Sen. Bob Brinson (R) and Rep. Eric Ager (D) discussed psychedelics reform following a screening of a documentary, In Waves and War, that followed three Navy SEALs who had life-changing experiences with plant medicine after serving . . .

Gov. Gavin Newsom’s veto comes at a time when medical cannabis sales continue to shrink, and medical cannabis products have become ‘virtually extinct.’

“Our findings suggest that broadening recreational marijuana access could help address the opioid epidemic.” The post Analysis: Adult-Use Marijuana Legalization Associated with Fewer Opioid Overdose Deaths appeared first on NORML.

The launch coincides with debates legislation that could recriminalize hemp-derived products containing measurable THC levels. Cannabis drinks now available at select Minnesota Target stores is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

The number of Americans who have ever smoked a marijuana blunt has risen by more than a fifth over a recent eight-year period, a new study shows. Examining data from the federally funded National Survey of Drug Use and Health (NSDUH), researchers found that “blunt smoking increased substantially from 2015 to 2022,” with the largest growth in use coming from women, older people and those who do not drink alcohol. “Much of the increase in blunt smoking was observed among groups with historically lower use rates,” the paper, which was published by the journal Addictive Behaviors, says. Overall, . . .

“To see the governor and members of the legislature be anti-business on this front is very concerning when other states have been able to figure this out.” By Megan Henry, Ohio Capital Journal Ohioans who sell intoxicating hemp products are worried what the 90-day ban that goes into effect on Tuesday will mean for their businesses and customers. Ohio Gov. Mike DeWine (R) recently announced a 90-day executive order that bans the sale of intoxicating hemp products that starts October 14. Intoxicating hemp products are items that contain THC that are sold anywhere other than licensed marijuana . . .

Registered patients can now obtain new Kynd brand flower offerings at AYR Wellness dispensaries statewide.

The governor of California has vetoed a bill that would have allowed certain marijuana microbusinesses to ship medical cannabis products directly to patients via common carriers like FedEx and UPS, stating that the proposal “would be burdensome and overly complex to administer.” After advancing through the legislature last month, the measure from Assemblymember Patrick Ahrens (D) was rejected by Gov. Gavin Newsom (D) on Saturday. “This bill would authorize a limited number of cannabis microbusinesses to ship certain medicinal cannabis products directly to patients using a common carrier,” the . . .

Vireo Growth Inc. Announces Closing of Acquisition of Outstanding Senior Secured Convertible Notes of Schwazze – Parties enter into Restructuring Support Agreement; Vireo to bid to acquire control of Schwazze assets – – Schwazze operates 63 dispensaries and 10 manufacturing facilities in Colorado and New Mexico – MINNEAPOLIS, Oct. 14, 2025 (GLOBE NEWSWIRE) – Vireo [ . . . ]

In trade associations, cannabis businesses can overpower the bitter taste of bad actors and advocate for improved policies.

A GOP senator says the time has come to create a federal “regulatory construct” for marijuana, while allowing states to decide to enact their own cannabis legalization laws. In one of his latest comments on the issue, Sen. Thom Tillis (R-NC) told Marijuana Moment in an interview that “we’ve got to get out of this mode” where states enacting their chosen cannabis policies are “running afoul of federal law.” “Now, in some cases, we seem to think that’s a bad thing” to have such disparate laws in place. “In the case of cannabis, we don’t. But it’s creating so many gateways for illegal and . . .

New York is tasked by law with keeping cannabis medical after adult-use legalization. How New York is keeping cannabis medical after legalization is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

The company’s joint venture with Top Tech Global includes a medical cannabis license issued by the National Directorate of Pharmacy and Drugs.

There’s nothing quite like growing your own cannabis at home. Watching a tiny seed turn into a beautiful, potent plant that twinkles with trichomes, smelling those first terpenes, knowing you did it all yourself, is unmatched. But for many people, the dream of growing at home hits a brick wall before they even get started. It’s easy to feel like you’ll mess it up and lose a bunch of time and cash. Thankfully, I Love Growing Marijuana (ILGM) is here to help ensure that doesn’t happen. A Dutch cannabis seed company operating exclusively in the US market, ILGM was built on a simple, powerful . . .

U.S. Attorney General Pam Bondi has indicated she will direct the Justice Department (DOJ) to investigate allegations by Sen. Thom Tillis (R-NC) that the Eastern Band of Cherokee Indians (EBCI) cannabis operation is marketing products to children and transporting products across boundary lines when making deliveries to its dispensary, the Asheville Citizen Times reports. During an October 8 hearing, Tillis told Bondi that he couldn’t “find any legal way” to get the cannabis products from the tribal land to the dispensary, which is in a non-contiguous part of the boundary. “This worries me . . .

A cannabis industry trade association in Michigan is suing the state over the newly approved wholesale cannabis tax, Michigan Advance reports. In the complaint, the Michigan Cannabis Industry Association argues that the tax violates the voter-approved adult cannabis use legalization law and that the 2018 law – which only imposed a 10% excise tax on retail sales – can only be modified by voters or a supermajority vote by lawmakers. The law was approved earlier this month by a 78-21 vote in the House, with 11 members not voting, and a 19-17 vote in the Senate. The group also contends that . . .

Kansas Bureau of Investigation (KBI) raids at 18 retailers in the state last week led to the seizure of more than 340 pounds of flower, 43,800 pre-rolls, 35,600 vapes, 84,480 THC and psilocybin edibles, and $35,430 in cash, the Kansas Reflector reports. The crackdown netted two arrests of individuals attempting to move the products while trying to evade law enforcement and the seizure of a truck that was transporting THC products removed from the shelves of shops targeted in the law enforcement action. During a press conference announcing the raids last Wednesday, KBI Director Tony Mattivi . . .

Michigan cannabis sales for September fell from a year ago as they fell sequentially by 11.3%, which was -8.3% on a per-day basis. At $251.3 million, sales were down 5.8% from a year earlier: The Michigan Cannabis Regulatory Agency breaks out sales by medical and adult-use, with medical sales falling 60.8% from a year ago to $0.4 [ . . . ]

The corporate Multi-State Operator (MSO) Curaleaf filed a lawsuit against the NJ Cannabis Regulatory Commission (NJ-CRC) in federal court over state labor laws. They believe it violates federal National Labor Relations Action (NLRA) laws. Curaleaf’s lawsuit was filed last week on October 9th. It has been assigned to the federal district court for New Jersey. [ . . . ] Source: MSO Curaleaf Lawsuit Filed Against NJ-CRC Over State Labor Law from Heady NJ

“Evidence is growing that psychedelics could hold the key to managing inflammation, one of the body’s central drivers of many chronic diseases, including depression, arthritis and heart conditions.” By Nicholas Barnes of the University of Birmingham, Via The Conversation Once synonymous with hippies and hallucinatory experiences, psychedelic drugs are now being explored for their medical potential. The stigma of that era resulted in research being suppressed by drug laws, yet with mental health treatments hitting limits, scientists have returned to this controversial corner of medicine. . . .

The Republican governor of Florida is conceding that “more people probably agreed” with a marijuana legalization ballot initiative he helped defeat last year than sided with his prohibitionist viewpoint-but he argued that it was the “morally right” choice for him to intervene to prevent the sale of “dangerous stuff” in his state. At an event hosted by the Pennsylvania Family Institute on Saturday, Gov. Ron DeSantis (R) talked about his administration’s uphill work to dissuade voters from approving both the cannabis measure as well as a separate reproductive rights initiative during the . . .

California’s governor has signed a bill aimed at streamlining research on marijuana and psychedelics. Gov. Gavin Newsom (D) on Friday gave final approval to the measure that empowers the Research Advisory Panel of California (RAPC) to expedite reviews of study proposals on Schedule I and Schedule II controlled substances, through January 2028. The newly enacted legislation, sponsored by Assemblymember Christopher Ward (D), will also authorize RAPC’s chair to assign two or more members of the body to conduct expedited reviews of research proposals and approve them on behalf of the panel. It . . .